MedPath

NARCAN NASAL SPRAY

NARCAN NASAL SPRAY

Approved
DIN Number

02458187

Drug Class

Human

Market Date

Jul 7, 2017

Company
HC

emergent operations ireland limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02458187
AIG Number0108981005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V03AB15 NALOXONE
Product Specifications
Dosage FormSpray, Metered Dose
Route of AdministrationNasal
AHFS Classification28:10.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

NALOXONE HYDROCHLORIDEActive
Strength: 4 MG / 0.1 ML
Monograph: NALOXONE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.